ACU (Acme United Corporation) Stock Analysis - Insider Trades
Acme United Corporation (ACU) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, ACU trades at $42.39 with a market cap of $158.51M and a P/E ratio of 16.84. ACU moved +0.14% today. Year to date, ACU is +5.32%; over the trailing twelve months it is +7.81%. Its 52-week range spans $34.35 to $47.31. Rallies surfaces ACU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading ACU stock inside the company?
Recent ACU insider activity includes OLSCHAN BRIAN S sold 1.00K, OLSCHAN BRIAN S sold 809, OLSCHAN BRIAN S sold 306, OLSCHAN BRIAN S sold 690, and OLSCHAN BRIAN S sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
ACU Key Metrics
Key financial metrics for ACU
Metric
Value
Price
$42.39
Market Cap
$158.51M
P/E Ratio
16.84
EPS
$2.51
Dividend Yield
0.16%
52-Week High
$47.31
52-Week Low
$34.35
Volume
1
Avg Volume
0
Revenue (TTM)
$202.88M
Net Income
$9.52M
Gross Margin
39.57%
Recent ACU Insider Trades
OLSCHAN BRIAN S sold 1.00K (~$40.05K) on Jun 3, 2025.
OLSCHAN BRIAN S sold 809 (~$32.32K) on Jun 2, 2025.
OLSCHAN BRIAN S sold 306 (~$12.21K) on May 20, 2025.
OLSCHAN BRIAN S sold 690 (~$27.53K) on May 19, 2025.
OLSCHAN BRIAN S sold 5.00K (~$199.75K) on May 16, 2025.
ACU analyst coverage data. Average price target: $0.00.
Common questions about ACU
Who is trading ACU stock inside the company?
Recent ACU insider activity includes OLSCHAN BRIAN S sold 1.00K, OLSCHAN BRIAN S sold 809, OLSCHAN BRIAN S sold 306, OLSCHAN BRIAN S sold 690, and OLSCHAN BRIAN S sold 5.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ACU?
Yes. Rallies tracks ACU insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ACU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACU. It does not provide personalized investment advice.